Optimi Health Corp.
Optimi Health Corp. (OPTI.CN) Financial Performance & Income Statement Overview
Analyze Optimi Health Corp. (OPTI.CN) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Optimi Health Corp. (OPTI.CN) Income Statement & Financial Overview
Explore comprehensive income reports for Optimi Health Corp. OPTI.CN, broken down by year and quarter.
| Metric | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $124027.00 | $82890.00 | $105074.00 | $19925.00 |
| Cost of Revenue | $56851.00 | $701060.00 | -$71049.00 | -$114893.00 |
| Gross Profit | $67176.00 | -$618170.00 | $176123.00 | $134818.00 |
| Gross Profit Ratio | $0.54 | -$7.46 | $1.68 | $6.77 |
| R&D Expenses | $176587.00 | $0.00 | $8613.00 | $5022.00 |
| SG&A Expenses | $661833.00 | $729952.00 | $1.003M | $1.27M |
| Operating Expenses | $838420.00 | $729952.00 | $1.30M | $1.43M |
| Total Costs & Expenses | $895271.00 | $1.43M | $1.22M | $1.32M |
| Interest Income | $0.00 | $3961.00 | $8835.00 | $6843.00 |
| Interest Expense | $99905.00 | $99384.00 | $96103.00 | $31075.00 |
| Depreciation & Amortization | $213450.00 | $220212.00 | $168171.00 | $85484.00 |
| EBITDA | -$778584.00 | -$1.12M | -$942344.00 | -$1.21M |
| EBITDA Ratio | -$6.28 | -$13.61 | -$8.97 | -$60.60 |
| Operating Income | -$771244.00 | -$1.35M | -$1.11M | -$1.29M |
| Operating Income Ratio | -$6.22 | -$16.26 | -$10.57 | -$64.89 |
| Other Income/Expenses (Net) | -$855513.00 | -$95423.00 | -$87268.00 | -$87064.00 |
| Income Before Tax | -$1.63M | -$1.44M | -$1.21M | -$1.32M |
| Income Before Tax Ratio | -$13.12 | -$17.42 | -$11.48 | -$66.45 |
| Income Tax Expense | $0.00 | -$2.00 | $35756.00 | $41672.00 |
| Net Income | -$1.63M | -$1.44M | -$1.24M | -$1.32M |
| Net Income Ratio | -$13.12 | -$17.42 | -$11.82 | -$66.45 |
| EPS | -$0.02 | -$0.02 | -$0.01 | -$0.02 |
| Diluted EPS | -$0.02 | -$0.02 | -$0.01 | -$0.02 |
| Weighted Avg Shares Outstanding | $89.59M | $87.93M | $86.07M | $87.04M |
| Weighted Avg Shares Outstanding (Diluted) | $89.59M | $87.93M | $86.07M | $87.04M |
Over the last four quarters, Optimi Health Corp.'s revenue moved from $19925.00 in Q4 2023 to $124027.00 in Q3 2024. Operating income in Q3 2024 was -$771244.00, with a strong operating margin of -622%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Optimi Health Corp. remained robust at -$778584.00, reflecting operational efficiency. Net income dropped to -$1.63M, with an EPS of -$0.02. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan